AUD

Clearmind Medicine to Pioneer Psychedelic Clinical Trials for Alcohol Use Disorder with Ivy League Universities

Retrieved on: 
Thursday, November 9, 2023
Patient, Clinical trial, Health, Crave, Psychiatry, MEAI, Safety, Depression, Johns Hopkins School of Medicine, AUD, Pharmaceutical industry

Tel Aviv, Israel / Vancouver, Canada, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. is pleased to announce that the company has entered into a Clinical Trial Agreement with Johns Hopkins University School of Medicine, to conduct its Phase I/IIa clinical trial of its proprietary MEAI-based CMND-100 as a potential treatment for Alcohol Use Disorder (AUD). The CM-CMND-001 clinical trial is a multinational, multi-center, single- and multiple-dose tolerability, safety and pharmacokinetic study in healthy volunteers and AUD subjects.

Key Points: 
  • The CM-CMND-001 clinical trial is a multinational, multi-center, single- and multiple-dose tolerability, safety and pharmacokinetic study in healthy volunteers and AUD subjects.
  • The patients will report their drinking patterns and craving for alcohol (and cigarettes) during the clinical trial period.
  • Johns Hopkins University School of Medicine is the second US-based medical site to join the Company’s clinical trial.
  • The potential of psychedelic drugs to treat various neuropsychiatric indications is currently being explored in multiple human clinical trials.

Canadian Psychedelic Trade Association Endorses Senate Report Calling for Research into Psychedelic-Assisted Therapy

Retrieved on: 
Wednesday, November 8, 2023
Psilocybin, Science, Government, Post-traumatic stress disorder, Parliament, Anxiety, MDMA, Veterans Affairs Canada, MDD, Chronic pain, Public, DND, Treatment, Health Canada, Veteran, Government of Canada, Doctor of Philosophy, Research, National security, Equitable Access to Care and Health Act, Canadian Institutes of Health Research, PTSD, OUD, CIHR, Atypical depression, DSM-IV codes, AUD, Partnership, VAC, TUD, House, Safety, Nicotine, Veterans' affairs, TRD, Mental health, Senate, Pharmaceutical industry, Nursing

OTTAWA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- PsyCan — the not-for-profit trade association of legally-operating Canadian psychedelic companies — enthusiastically endorses a new report by the Senate of Canada Subcommittee on Veteran Affairs urging federal, provincial, and territorial governments to launch and fund a large-scale research program into psychedelic-assisted therapy.

Key Points: 
  • OTTAWA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- PsyCan — the not-for-profit trade association of legally-operating Canadian psychedelic companies — enthusiastically endorses a new report by the Senate of Canada Subcommittee on Veteran Affairs urging federal, provincial, and territorial governments to launch and fund a large-scale research program into psychedelic-assisted therapy.
  • While Canada is a leader in developing these innovative treatments, many barriers remain to patient access, and government must play an active role.
  • “This report echoes our calls for government funding into psychedelic-assisted therapy,” said PharmAla Biotech CEO and PsyCan Chair Nick Kadysh.
  • “Research on these subjects is constantly evolving and will continue to do so.

eBay Inc. Reports Third Quarter 2023 Results

Retrieved on: 
Tuesday, November 7, 2023
American City Business Journals, Silicon, Development, Gross merchandise volume, British Fashion Council, Face, EBay, FX, GAAP, All Hallows College, Magic, EBAY, Magic: The Gathering, Jewellery, GMV, France, Gardening, SAN, AUD, Iron ore, Bank, Holding company, Auction, Management, Video game, Online shopping, Q3, Legend

"We delivered another quarter of solid results, and have accelerated the pace of innovation across eBay," said Jamie Iannone, Chief Executive Officer at eBay.

Key Points: 
  • "We delivered another quarter of solid results, and have accelerated the pace of innovation across eBay," said Jamie Iannone, Chief Executive Officer at eBay.
  • During the quarter, eBay authenticated its millionth trading card: a Magic: The Gathering All Hallow's Eve (Legends) card.
  • The eBay Foundation announced its 2023 Global Give grantees, awarding nearly $3 million to 32 nonprofit grantees across the globe.
  • Third Quarter 2023 Financial Highlights (presented in millions, except per share data and percentages)

Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine Conference

Retrieved on: 
Tuesday, October 31, 2023
Irish Cave Rescue Organisation, Drinking, Health, Conference, Addiction medicine, ISAM, Medicine, International Society, Patient, Death, The Annual, AUD, Pharmaceutical industry

“Millions of people suffer from alcohol use disorder and only a small percentage of this population seek medical treatment.

Key Points: 
  • “Millions of people suffer from alcohol use disorder and only a small percentage of this population seek medical treatment.
  • In addition, over 140,000 people die from alcohol-related causes annually, making alcohol the fourth-leading preventable cause of death in the United States alone.
  • We are proud to be making significant progress in developing a precision-based medicine that can potentially reduce drinking, thereby aiding in the overall health of patients.
  • We look forward to discussing AD04, Adial’s lead compound, at the ISAM annual conference,” commented Professor Dr. Bankole Johnson.

Audacy Provides NYSE Listing Update

Retrieved on: 
Monday, October 30, 2023
Technology, Audio, Video, Entertainment, Business, Finance, Apps, Applications, Media, Podcast, General Entertainment, Professional Services, Public Relations, Investor Relations, Communications, TV and Radio, Music, Common stock, AUDA, Growth, Security (finance), Securities and Exchange Commission (Nigeria), NYSE, Audacy, Inc., AUD, Cryptocurrency

Audacy, Inc. (NYSE: AUD; OTC: AUDA) (the “Company” or “Audacy”) today announced that its appeal of the determination by the New York Stock Exchange (“NYSE”) to commence proceedings to delist Audacy’s Class A Common Stock (the “Common Stock”) from the NYSE was not successful.

Key Points: 
  • Audacy, Inc. (NYSE: AUD; OTC: AUDA) (the “Company” or “Audacy”) today announced that its appeal of the determination by the New York Stock Exchange (“NYSE”) to commence proceedings to delist Audacy’s Class A Common Stock (the “Common Stock”) from the NYSE was not successful.
  • As a result, the NYSE today filed a Form 25 relating to the delisting from the NYSE of its Common Stock with the Securities and Exchange Commission (the “SEC”), which will become effective on or about November 10, 2023.
  • Audacy stock has not been traded on the NYSE since May when the NYSE notified Audacy that it had elected to commence proceedings to delist the Common Stock from the NYSE based on Audacy’s “abnormally low” price levels.
  • Audacy continues to focus on growing and enhancing its capabilities as a leading, multi-platform audio content and entertainment company, and continues to engage in discussions with its lenders to deleverage its balance sheet and improve its capital structure to position Audacy for long-term growth.

UWorld Launches All-New CPA Exam Review Product to Prepare Candidates for the 2024 CPA Evolution

Retrieved on: 
Wednesday, November 1, 2023
Knowledge, REG, Tax, AICPA, MD, Comprehension, Uniform Certified Public Accountant Examination, FAR, AUD, Student, International Federation of Accountants, Tax advisor, Nursing, Real estate, DALLAS

DALLAS, Nov. 1, 2023 /PRNewswire/ -- UWorld, a worldwide leader in learning tools for high-stakes exams, today launched its 2024 CPA Review Course to prepare aspiring accounting professionals for the 2024 CPA Exam. With proven methodology resulting in a historic 94% CPA Exam pass rate and industry-leading resources, UWorld Accounting's 2024 product provides streamlined content to help candidates study smarter and pass faster.

Key Points: 
  • DALLAS, Nov. 1, 2023 /PRNewswire/ -- UWorld , a worldwide leader in learning tools for high-stakes exams, today launched its 2024 CPA Review Course to prepare aspiring accounting professionals for the 2024 CPA Exam.
  • With proven methodology resulting in a historic 94% CPA Exam pass rate and industry-leading resources, UWorld Accounting's 2024 product provides streamlined content to help candidates study smarter and pass faster.
  • The technology offers data-supported goals based on previously successful CPA Exam candidates to help users gauge their preparedness for exam day.
  • "We are thrilled to launch our 2024 CPA product to meet the latest developments with the CPA Exam," said Chandra S. Pemmasani, MD, Founder and CEO of UWorld.

White Spark Pictures Launches Surround Sync - A New Tech Business Set to Enable the First True Virtual Reality Cinema

Retrieved on: 
Wednesday, November 1, 2023
Atmos, VR, Dolby Atmos, Sport, Photography, High School of Enterprise, Business, & Technology, Virtual reality, MD, Physical attractiveness stereotype, Friends, Software, Museum, Screen Australia, AUD, Film industry, Entertainment

PERTH, Australia, Nov. 1, 2023 /PRNewswire/ -- White Spark Pictures, the Australian-based VR and TV production company, is excited to announce the launch of a new standalone technology business, Surround Sync.

Key Points: 
  • PERTH, Australia, Nov. 1, 2023 /PRNewswire/ -- White Spark Pictures, the Australian-based VR and TV production company, is excited to announce the launch of a new standalone technology business, Surround Sync.
  • Surround Sync tech represents a major innovation in the entertainment industry, supporting and helping to grow the development of virtual reality to finally bring true virtual reality cinema experiences to mass audiences.
  • The Surround Sync system is a first-of-its-kind technology that uniquely delivers shared immersive experiences at scale by simultaneously and seamlessly synchronising cinema theatre screens and surround sound with hundreds of VR headsets.
  • "Now, with proven technical and commercial success, the time is right to officially launch the new Surround Sync business.

Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorder in Adial Pharmaceuticals Key Opinion Leader Webinar

Retrieved on: 
Wednesday, October 25, 2023
FDA, Drinking, National Institute on Alcohol Abuse and Alcoholism, Therapy, Physician, Mortality, Disease, MBA, Research, United, Disorder, Substance Abuse and Mental Health Services Administration, Quality, Public, Patient, NIAAA, Bias, Death, Socialization, Table, Addiction, AUD, Pharmaceutical industry, Birth control, Nursing, Health, Alcoholism

Both experts are nationally recognized for their efforts in providing improved treatment options to patients with AUD.

Key Points: 
  • Both experts are nationally recognized for their efforts in providing improved treatment options to patients with AUD.
  • Among the patients in treatment with these medications, adherence is a significant concern, with side effects being a common reason given for stopping the medication.
  • To improve engagement in medical treatment, the key opinion leaders expressed the belief that barriers to treatment could be reduced by giving people additional options such as non-abstinence-based therapies.
  • A non-abstinence-based treatment approach will provide patients with the power to choose more realistic goals of reducing alcohol consumption rather than abstinence.

Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Retrieved on: 
Tuesday, October 24, 2023
Sale, Security (finance), Regulation D, Act, Exercise, Disorder, Addiction, AUD

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

Key Points: 
  • H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
  • The series A and the series B warrants have an exercise price of $2.82 per share and will become exercisable on the effective date of stockholder approval for the issuance of the shares upon exercise of the warrants (or payment of $0.125 per share).
  • The series A warrants will expire five and one-half years from the date of issuance and the series B warrants will expire eighteen months from the date of issuance.
  • The gross proceeds to the Company from the private placement are approximately $4 million, before deducting the placement agent’s fees and other offering expenses payable by the Company.

Hydrostor Expands Australian Government Affairs Team and Announces Participation at All Energy Australia Conference

Retrieved on: 
Sunday, October 22, 2023
Government, SCES, Jordan, Chief commercial officer, Regulatory affairs, AUD, Renewable energy, NSW

MELBOURNE, AUSTRALIA, Oct. 22, 2023 (GLOBE NEWSWIRE) -- Hydrostor, a leading global long duration energy storage (LDES) developer and operator, expands its presence with the appointment of Sara Taylor to direct its Government & Regulatory Affairs initiatives in Australia.

Key Points: 
  • MELBOURNE, AUSTRALIA, Oct. 22, 2023 (GLOBE NEWSWIRE) -- Hydrostor, a leading global long duration energy storage (LDES) developer and operator, expands its presence with the appointment of Sara Taylor to direct its Government & Regulatory Affairs initiatives in Australia.
  • Sara will play a key role in advancing clean energy policies in the Australian market, with a focus on the deployment of Hydrostor’s Advanced Compressed Air Energy Storage (A-CAES) technology.
  • A-CAES is set to be an essential component in Australia’s flexible, secure, scalable, and affordable clean energy future.
  • Sara has over a decade of regulatory and compliance experience across the Australian energy sector, including roles with regulators, retailers, and network businesses.